India’s Covid-19 Vaccines Effective Against New Variants, Says ICMR
Updated On Feb 19, 2021
According to the Indian Council of Medical Research (ICMR), interim results of the ongoing clinical trial depict that Covid-19 vaccines developed in India show effectiveness against the new coronavirus variants. The Indian vaccines are reportedly effective against the United Kingdom, South African and Brazil variants.
ICMR Director-General Dr. Balram Bhargava informed that the interim analysis report will be out in a week’s time. Furthermore, the third clinical trial of Covaxin BB152 has been completed as all the 25,800 volunteers involved in the exercise have been administered both the novel coronavirus vaccine doses.
Dr. Bhargava also stated that a paper on Bharat Biotech’s Covaxin’s neutralisation potential against the UK strain has been accepted for publication. In the case of the South African and Brazil variants, efforts to isolate the mutated virus strains from the samples collected were going on. He also shed light on the fact that India was the 5th country in the world to isolate the virus in order to develop a vaccine for the coronavirus pandemic.
The ICMR had recently announced that the South African variant of coronavirus spreading in more than 44 countries has marked its entry in India as 4 people having been detected with the strain.
It must be noted that India has also reported 1 case of the Brazilian strain of the coronavirus.
You May Also Like To Read: Coronavirus Vaccine: What You Can And Cannot Do After Getting Vaccinated?
Disclaimer: This article is issued in the general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.